Policy Coherence in US Tobacco Control: Beyond FDA Regulation
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Fooks G, Gilmore A Tob Control. 2013; 23(1):e1.
PMID: 23788606 PMC: 3888632. DOI: 10.1136/tobaccocontrol-2012-050869.
Tesler L, Malone R Am J Public Health. 2010; 100(7):1174-88.
PMID: 20466958 PMC: 2882403. DOI: 10.2105/AJPH.2009.179150.
Compromise or capitulation? US Food and Drug Administration jurisdiction over tobacco products.
Glantz S, Barnes R, Eubanks S PLoS Med. 2009; 6(7):e1000118.
PMID: 19636359 PMC: 2709428. DOI: 10.1371/journal.pmed.1000118.
References
1.
Delnevo C, Bauer U
. Monitoring the tobacco use epidemic III: The host: data sources and methodological challenges. Prev Med. 2008; 48(1 Suppl):S16-23.
DOI: 10.1016/j.ypmed.2008.09.008.
View
2.
Lightwood J, Dinno A, Glantz S
. Effect of the California tobacco control program on personal health care expenditures. PLoS Med. 2008; 5(8):e178.
PMC: 2522256.
DOI: 10.1371/journal.pmed.0050178.
View
3.
Baba A, Cook D, McGarity T, Bero L
. Legislating "sound science": the role of the tobacco industry. Am J Public Health. 2005; 95 Suppl 1:S20-7.
DOI: 10.2105/AJPH.2004.050963.
View
4.
Mokdad A, Marks J, Stroup D, Gerberding J
. Actual causes of death in the United States, 2000. JAMA. 2004; 291(10):1238-45.
DOI: 10.1001/jama.291.10.1238.
View
5.
. State Medicaid coverage for tobacco-dependence treatments--United States, 2005. MMWR Morb Mortal Wkly Rep. 2006; 55(44):1194-7.
View